Capital Management Associates (New York) Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MP Materials
MP
|
+$1.1M |
| 2 |
Freeport-McMoran
FCX
|
+$1.09M |
| 3 |
Celestica
CLS
|
+$1.05M |
| 4 |
CVS Health
CVS
|
+$803K |
| 5 |
Micron Technology
MU
|
+$637K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bloom Energy
BE
|
+$1.02M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.8% |
| 2 | Industrials | 18.56% |
| 3 | Healthcare | 8.56% |
| 4 | Financials | 7.9% |
| 5 | Consumer Discretionary | 7.18% |
No holdings matched the selected filter criteria.
Similar funds
Capital Management Associates (New York)'s Q2 2026 Portfolio in Review
As of Q2 2026, Capital Management Associates (New York) held 44 positions worth $77.7M, up 29% from $60.2M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Capital Management Associates (New York) deployed $5.29M of net new capital in Q2 2026, opening 8 new positions. Its largest new stake was MP Materials: 18,000 shares worth $1.01M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 25% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was Bloom Energy, an estimated $1.02M trimmed.
- Capital Management Associates (New York)'s largest Q2 2026 buy was MP Materials: 18,000 shares worth $1.01M.
- Capital Management Associates (New York)'s biggest Q2 2026 reduction was Bloom Energy, cutting an estimated $1.02M.
- Capital Management Associates (New York)'s ten largest holdings make up 46% of its $77.7M portfolio in Q2 2026.
- Capital Management Associates (New York) opened 8 new positions and closed 0 in Q2 2026.
- Capital Management Associates (New York)'s portfolio value rose 29% quarter-over-quarter to $77.7M.
Based on Capital Management Associates (New York)'s 13F filing for Q2 2026, filed 10 Aug 2026.